Clinical Trial Update: Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating cromoglicate as adjunctive therapy for outpatients with schizophrenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Cromogulate (cromoglicate)

Snippet

Sponsor: Vishwajit Nimgaonkar, MD PhD | Conditions: Schizophrenia, Schizo Affective Disorder | Phase 1, Phase 2 | Status: RECRUITING